Status:
TERMINATED
Wearable Bioimpedance Analyzer for Tracking Body Composition Changes
Lead Sponsor:
University of Iowa
Conditions:
Obesity
Knee Osteoarthritis
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
Obesity, namely at body mass index (BMI) levels exceeding 40kg/m2 (class III obesity), is a risk factor for many diseases including osteoarthritis (OA). In arthroplasty, patients in this population fr...
Eligibility Criteria
Inclusion
- Adults \>/= 18 years
- BMI \> 40kg/m2
- Presenting to bariatric arthroplasty clinic with desire for total joint arthroplasty procedure
- Owns a smartphone capable of handling iOS or Google Play apps
- Has a wrist circumference less than or equal to 7.7"
Exclusion
- Has a pacemaker or other electronic pacemaker placement
- Inability to complete study protocols
- Inability to stand unsupported for 60-90 seconds
- Does not own a smart phone capable of handling iOS or Google Play apps
- Has a wrist circumference greater than 7.7"
Key Trial Info
Start Date :
July 14 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 8 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05986617
Start Date
July 14 2023
End Date
October 8 2024
Last Update
December 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Iowa Hospitals & Clinics
Iowa City, Iowa, United States, 52242